The companies plan to connect GE HealthCare imaging and software with Leo Cancer Care’s upright radiation therapy technology, with a focus on interoperability and streamlined data flow.
Leo Cancer Care and GE HealthCare have entered a commercial collaboration to bring connected imaging and radiation therapy workflows to the market. Under the agreement, the companies intend to integrate GE HealthCare’s imaging solutions and Intelligent Radiation Therapy (iRT) software with Leo Cancer Care’s future upright radiation therapy technology.
The partnership aims to streamline patient and data workflows from the simulation phase through to treatment. According to the companies, the collaboration addresses industry challenges such as multivendor environments, system interoperability, and the length of time between imaging and the start of treatment.
“Bringing imaging, planning, and treatment closer together in radiation therapy has the potential to make a meaningful difference for both patients and care teams,” says Ben Newton, global head of oncology at GE HealthCare, in a release. “By working with both iRT and Leo Cancer Care’s innovative upright treatment approach, we see an exciting opportunity to explore a more connected, patient-centered model of radiation therapy that could help simplify workflows and reduce the time from imaging to treatment.”
The companies plan to explore how the iRT software, an AI-supported solution, can connect information and applications across systems to reduce the workflow burden for clinicians. The software is designed to support more timely progression through the radiation therapy pathway.
“GE HealthCare is one of the most established names in medical imaging anywhere in the world,” says Stephen Towe, CEO of Leo Cancer Care, in a release. “Its decision to partner with Leo Cancer Care, is a clear signal that upright radiation therapy is being recognised at the highest levels of our industry.”
The agreement is non-exclusive, allowing both organizations to continue working within the broader radiation oncology ecosystem. The goal is to develop interoperable solutions that complement existing clinical infrastructure rather than replace it. The companies also hope to address the cost and complexity of treatment infrastructure and improve access to advanced technology.
ID 36782210 © Alphaspirit | Dreamstime.com
